Boyle IT - Search Results

1

Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease.

Boyce BF, Smith L, Fogelman I, Johnston E, Ralston S, Boyle IT. Boyce BF, et al. Among authors: boyle it. Lancet. 1984 Apr 14;1(8381):821-4. doi: 10.1016/s0140-6736(84)92272-4. Lancet. 1984. PMID: 6143140

2

Hypercalcaemic osteomalacia due to aluminium toxicity.

Boyce BF, Fell GS, Elder HY, Junor BJ, Elliot HL, Beastall G, Fogelman I, Boyle IT. Boyce BF, et al. Among authors: boyle it. Lancet. 1982 Nov 6;2(8306):1009-13. doi: 10.1016/s0140-6736(82)90049-6. Lancet. 1982. PMID: 6127501 Clinical Trial.

3

Mineralisation defects with pamidronate therapy for Paget's disease.

Adamson BB, Gallacher SJ, Byars J, Ralston SH, Boyle IT, Boyce BF. Adamson BB, et al. Among authors: boyle it. Lancet. 1993 Dec 11;342(8885):1459-60. doi: 10.1016/0140-6736(93)92935-m. Lancet. 1993. PMID: 7902484

4

Mineralisation defects after pamidronate for Paget's disease.

Boyce BF, Adamson BB, Gallacher SJ, Byars J, Ralston SH, Boyle IT. Boyce BF, et al. Among authors: boyle it. Lancet. 1994 May 14;343(8907):1231-2. doi: 10.1016/s0140-6736(94)92446-5. Lancet. 1994. PMID: 7909901 No abstract available.

5

Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia.

Ralston SH, Gardner MD, Dryburgh FJ, Jenkins AS, Cowan RA, Boyle IT. Ralston SH, et al. Among authors: boyle it. Lancet. 1985 Oct 26;2(8461):907-10. doi: 10.1016/s0140-6736(85)90848-7. Lancet. 1985. PMID: 2865417 Clinical Trial.

6

The effect of 1 alpha-hydroxyvitamin D3 on the mineralization defect in disodium etidronate-treated Paget's disease--a double-blind randomized clinical study.

Ralston SH, Boyce BF, Cowan RA, Fogelman I, Smith ML, Jenkins A, Boyle IT. Ralston SH, et al. Among authors: boyle it. J Bone Miner Res. 1987 Feb;2(1):5-12. doi: 10.1002/jbmr.5650020103. J Bone Miner Res. 1987. PMID: 3137773 Clinical Trial.

7

Diphosphonates and inhibition of bone mineralisation.

Boyce BF, Smith L, Fogelman I, Ralston S, Boyle IT. Boyce BF, et al. Among authors: boyle it. Lancet. 1982 Apr 24;1(8278):964-5. doi: 10.1016/s0140-6736(82)91962-6. Lancet. 1982. PMID: 6122797 No abstract available.

8

Hypercalcaemia and metastatic bone disease: is there a causal link?

Ralston S, Fogelman I, Gardner MD, Boyle IT. Ralston S, et al. Among authors: boyle it. Lancet. 1982 Oct 23;2(8304):903-5. doi: 10.1016/s0140-6736(82)90868-6. Lancet. 1982. PMID: 6126753

9

Correlation of skeletal uptake of 99mTc-diphosphonate and alkaline phosphatase before and after oral diphosphonate therapy in Paget's disease.

Smith ML, Fogelman I, Ralston S, Boyce BF, Boyle IT. Smith ML, et al. Among authors: boyle it. Metab Bone Dis Relat Res. 1984;5(4):167-70. doi: 10.1016/0221-8747(84)90024-9. Metab Bone Dis Relat Res. 1984. PMID: 6429474

10

The role of bone scanning in Paget's disease.

Fogelman I, Carr D, Boyle IT. Fogelman I, et al. Among authors: boyle it. Metab Bone Dis Relat Res. 1981;3(4-5):243-54. doi: 10.1016/0221-8747(81)90040-0. Metab Bone Dis Relat Res. 1981. PMID: 6762482 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132 results

Search Page

Filters